Adult ID

Pediatric ID

HIV/TB/STD

Global ID

Oral Abstract

96 - HIV Viral Suppression or Bust

Presentations:

• 3:15 PM - 3:30 PM

  883 - Evidence from a Multistate Cohort: Enrollment in Affordable Care Act Qualified Health Plans Results in Viral Suppression
  Kathleen A. McManus, MD, MSCR – University of Virginia; Bianca B. Christensen, MPH – University of Nebraska Medical Center; V P. Nagraj – University of Virginia; Elizabeth T. Rogawski McQuade, PhD MSPH – University of Virginia; Renae Furl, MPH – Nebraska Department of Health and Human Services; Lauren Yerkes, MPH – Virginia Department of Health; Susan Swindells, MBBS – University of Nebraska Medical Center; Sharon Weissman, MD – University of South Carolina; Anne Rhodes, PhD – Virginia Department of Health; Paul V. Targonski, MD, PhD – University of Virginia; Rebecca Dillingham, MD, MPH – University of Virginia
• 3:30 PM - 3:45 PM

  884 - Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies
  Paula Teichner, PharmD – ViiV Healthcare; Amy Cutrell, MS – ViiV Healthcare; Ronald D'Amico, DO, MSc – ViiV Healthcare; David Dorey, MMATH – GSK; Sandy Griffith, PharmD – ViiV Healthcare; Conn M. Harrington, BA – ViiV Healthcare; Jenny Huang, Msc – GSK; Krischan J. Hudson, PhD, MPH – ViiV Healthcare; David Margolis, MD, MPH – ViiV Healthcare; Joseph Mrus, MD, MSc – ViiV Healthcare; Joseph Polli, PhD, FAAPS – ViiV Healthcare; William Spreen, PharmD – ViiV Healthcare; Peter Williams, Ph.D. – Janssen Research & Development, LLC; Rodica Van Solingen-Ristea, MD – Janssen Research & Development, LLC; Mark S. Shaefer, PharmD – ViiV Healthcare
• 3:45 PM - 4:00 PM

  885 - HIV-1 Treatment Failure and Extensive Drug Resistance in Perinatally-Infected Children Failing First-Line Antiretroviral Therapy in Western Kenya
  Winstone Nyandiko, MD – Academic Model Providence Access to Healthcare (AMPATH); Sabina Holland, MD – Brown University; Rachel Vreeman, MD – Indiana University; Allison DeLong, MS – Brown University; Akarsh Manne, MS – Brown University; Vladimir Novitsky, MD, PhD – Brown University; Mia Coetzer, PhD – Brown University; Anthony Ngeresa, BS – Academic Model Providence Access to Healthcare (AMPATH); Carole McAteer, MPH – Indiana University; Josephine Aluoch, BS – Academic Model Providence Access to Healthcare (AMPATH); Millicent Orido, BS – Academic Model Providence Access to Healthcare (AMPATH); Soya Sam, PhD – Lifespan; Angela Caliendo, MD, PhD – Brown University; Samuel Ayaya, MD – Academic Model Providence Access to Healthcare (AMPATH); Joseph Hogan, PhD – Brown University; Rami Kantor, MD – Brown University
• 4:00 PM - 4:15 PM

  886 - Pregnancy Outcomes Following Raltegravir Exposure
  Hala Shamsuddin, MD – Merck & Co., Inc.; Casey Raudenbush, MSN/CRNP – Merck Sharp & Dohme; Brittany Sciba, BSN – Merck & Co., Inc.; Erica N. Gooch, PharmD – Merck & Co., Inc.; Wayne Greaves, MD – Merck Research Labs; Ronald W. Leong, MD – Merck & Co., Inc.; Walter Straus, M.D., M.P.H. – Merck & Co., Inc.
• 4:15 PM - 4:30 PM

  887 - High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) With the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg Regardless of Baseline Disease Characteristics: Week 48 Subgroup Analyses From the Phase 3 DIAMOND Trial
  Gregory D. Huhn, MD – The Ruth M. Rothstein CORE Center; Moti Ramgopal, MD – Midway Immunology and Research Center; Gordon Crofoot, MD – Crofoot Research Center; Joseph Gathe, Jr., MD – Therapeutic Concepts; Sareh Seyedkazemi, PharmD – Janssen Scientific Affairs, LLC; Patricia Cosler, PharmD – Janssen Scientific Affairs, LLC; Richard Bruce Simonson, BS – Janssen Scientific Affairs, LLC; Donghan Luo, PhD – Janssen Research & Development, LLC; Keith Dunn, PharmD – Janssen Scientific Affairs, LLC

Co-Author(s)

• WN

  Winstone Nyandiko, MD

  Professor
  Academic Model Providence Access to Healthcare (AMPATH)
  Eldoret, Western, Kenya

  Disclosure: Nothing to disclose
• BC

  Bianca Christensen, MPH

  Medical Student
  University of Nebraska Medical Center
  Omaha, NE

  Disclosure: Nothing to disclose
• AC

  Amy Cutrell, MS

  Director Statistics
  ViiV Healthcare
  Research Triangle Park, NC

  Disclosure: ViiV Healthcare: Employee
• MR

  Moti Ramgopal, MD

  Consultant Physician/Director Associates in Infectious Diseases
  Midway Immunology and Research Center
  Fort Pierce, FL

  Disclosure: AbbVie: Speaker's Bureau
  Allergan: Speaker's Bureau
  Gilead: Advisor or Review Panel member, Speaker's Bureau
  Insamed: Speaker's Bureau
  Janssen: Advisor or Review Panel member, Speaker's Bureau
  Merck: Advisor or Review Panel member
  ViiV: Advisor or Review Panel member, Speaker's Bureau
• CR

  Casey Raudenbush, MSN/CRNP

  Associate Principal Scientist
  Merck Sharp & Dohme
  Upper Gwynedd, PA

  Disclosure: Merck: Employee
• GC

  Gordon Crofoot, MD

  Owner
  Crofoot Research Center
  Houston, TX

  Disclosure: Gilead: Grant/Research Support
  Janssen: Grant/Research Support
  Merck: Grant/Research Support
  ViiV: Grant/Research Support
• RD

  Ronald D'Amico, DO, MSc

  Medical Director
  ViiV Healthcare
  Research Triangle Park, NC

  Disclosure: ViiV Healthcare: Employee
• VN

  V Nagraj

  Data Analyst
  University of Virginia
  Charlottesville, VA

  Disclosure: Nothing to disclose
• BS

  Brittany Sciba, BSN

  Scientist
  Merck & Co., Inc.
  North Wales, PA

  Disclosure: Merck: Employee
• RV

  Rachel Vreeman, MD

  Associate Professor
  Indiana University
  Indianapolis, IN

  Disclosure: Nothing to disclose
• AD

  Allison DeLong, MS

  Biostatistician
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose
• DD

  David Dorey, MMATH

  Statistician
  GSK
  Mississauga, ON, Canada

  Disclosure: GlaxoSmithKline: Employee, Shareholder
• JG

  Joseph Gathe, Jr., MD

  Medical Director
  Therapeutic Concepts
  Houston, TX

  Disclosure: Abbott: Scientific Research Study Investigator
  AbbVie: Grant/Research Support, Other Financial or Material Support, Consultant or speaker in company-supported conferences
  Avexa: Scientific Research Study Investigator
  Boehringer Ingelheim: Grant/Research Support, Scientific Research Study Investigator
  Bristol-Myers Squibb: Grant/Research Support, Other Financial or Material Support, Consultant or speaker in company-supported conferences
  Gilead: Grant/Research Support, Scientific Research Study Investigator, Consultant or speaker in company-supported conferences
  GlaxoSmithKline: Grant/Research Support, Scientific Research Study Investigator, Other Financial or Material Support, Consultant or speaker in company-supported conferences
  Hiesped: Scientific Research Study Investigator
  Janssen: Grant/Research Support, Scientific Research Study Investigator, Consultant or speaker in company-supported conferences
  Merck: Grant/Research Support, Scientific Research Study Investigator, Consultant or speaker in company-supported conferences
  Parexel: Scientific Research Study Investigator
  Pfizer: Grant/Research Support, Scientific Research Study Investigator
  Roche: Scientific Research Study Investigator
  ViiV: Grant/Research Support, Other Financial or Material Support, Consultant or speaker in company-supported conferences
• EG

  Erica Gooch, PharmD

  Medical Associate, Clinical Safety & Risk Management
  Merck & Co., Inc.
  Philadelphia, PA

  Disclosure: Merck: Employee
• ER

  Elizabeth Rogawski McQuade, PhD MSPH

  Assistant Professor
  University of Virginia
  Charlottesville, VA

  Disclosure: Nothing to disclose
• RF

  Renae Furl, MPH

  Infectious Diseases Program Manager
  Nebraska Department of Health and Human Services
  Omaha, NE

  Disclosure: Nothing to disclose
• WG

  Wayne Greaves, MD

  Executive Director
  Merck Research Labs
  Edison, NJ

  Disclosure: Merck: Employee
• SG

  Sandy Griffith, PharmD

  Director Clinical Development
  ViiV Healthcare
  Research Triangle Park, NC

  Disclosure: ViiV Healthcare: Employee, GSK shareholder
• AM

  Akarsh Manne, MS

  Senior Research Assistant
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose
• SS

  Sareh Seyedkazemi, PharmD

  Disease Area Strategic Coordinator
  Janssen Scientific Affairs, LLC
  Titusville, NJ

  Disclosure: Janssen: Employee, Shareholder
• PC

  Patricia Cosler, PharmD

  Senior Medical Science Liaison
  Janssen Scientific Affairs, LLC
  Titusville, NJ

  Disclosure: Janssen: Employee, Shareholder
• CH

  Conn Harrington, BA

  Clinical Investigation Lead
  ViiV Healthcare
  Research Triangle Park, NC

  Disclosure: ViiV Healthcare: Employee
• RL

  Ronald Leong, MD

  Distinguished Scientist/Executive Director
  Merck & Co., Inc.
  North Wales, PA

  Disclosure: Merck & CO, INC: Employee
• VN

  Vladimir Novitsky, MD, PhD

  Principal Research Scientist
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose
• LY

  Lauren Yerkes, MPH

  Epidemiologist
  Virginia Department of Health
  Richmond, VA

  Disclosure: Nothing to disclose
• MC

  Mia Coetzer, PhD

  Assistant Professor
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose
• JH

  Jenny Huang, Msc

  statistician
  GSK
  mississauga, ON, Canada

  Disclosure: GlaxoSmithKline: Employee
• RS

  Richard Bruce Simonson, BS

  Director, Clinical Project Scientist Medical Affairs, Infectious Diseases
  Janssen Scientific Affairs, LLC
  Titusville, NJ

  Disclosure: Janssen: Employee, Shareholder
• WS

  Walter Straus, M.D., M.P.H.

  Vice-President
  Merck & Co., Inc.
  North Wales, PA

  Disclosure: Merck: Employee
• SS

  Susan Swindells, MBBS

  Professor, Division of Infectious Diseases
  University of Nebraska Medical Center
  Omaha, NE

  Disclosure: ViiVHealthcare: Grant/Research Support
• KH

  Krischan Hudson, PhD, MPH

  Director of Clinical Development
  ViiV Healthcare
  Research Triangle Park, NC

  Disclosure: ViiV Healthcare: Employee
• DL

  Donghan Luo, PhD

  Associate Director, Medical Affairs Biostatistics
  Janssen Research & Development, LLC
  Titusville, NJ

  Disclosure: Janssen: Employee, Shareholder
• AN

  Anthony Ngeresa, BS

  Research Data Manager
  Academic Model Providence Access to Healthcare (AMPATH)
  Eldoret, Western, Kenya

  Disclosure: Nothing to disclose
• SW

  Sharon Weissman, MD

  Professor of Medicine
  University of South Carolina
  Columbia, SC

  Disclosure: Nothing to disclose
• KD

  Keith Dunn, PharmD

  Medical Director, Infectious Diseases
  Janssen Scientific Affairs, LLC
  Titusville, NJ

  Disclosure: Janssen: Employee, Shareholder
• DM

  David Margolis, MD, MPH

  Director of HIV Drug Development
  ViiV Healthcare
  Research Triangle Park, North Carolina

  Disclosure: ViiV Healthcare: Employee, Shareholder, Other Financial or Material Support, Salary and stock options
• CM

  Carole McAteer, MPH

  Program Manager
  Indiana University
  Indianapolis, IN

  Disclosure: Nothing to disclose
• AR

  Anne Rhodes, PhD

  Deputy Director, Division of Disease Prevention
  Virginia Department of Health
  Richmond, VA

  Disclosure: Nothing to disclose
• JA

  Josephine Aluoch, BS

  Program Manager
  Academic Model Providence Access to Healthcare (AMPATH)
  Eldoret, Western, Kenya

  Disclosure: Nothing to disclose
• JM

  Joseph Mrus, MD, MSc

  Executive Medical Director
  ViiV Healthcare
  Cary, NC

  Disclosure: ViiV Healthcare: Employee
• PT

  Paul Targonski, MD, PhD

  Associate Professor, Director for Clinical Research Initiatives
  University of Virginia
  Charlottesville, VA

  Disclosure: Nothing to disclose
• RD

  Rebecca Dillingham, MD, MPH

  Associate Professor
  University of Virginia
  Charlottesville, VA

  Disclosure: Gilead: Research Grant or Support
  NIH: Grant/Research Support
  Virginia Department of Health: Grant/Research Support
  Warm Health Technology: Consultant
• MO

  Millicent Orido, BS

  Laboratory Technologist
  Academic Model Providence Access to Healthcare (AMPATH)
  Eldoret, Western, Kenya

  Disclosure: Nothing to disclose
• JP

  Joseph Polli, PhD, FAAPS

  Director, Medical Information and Scientific Communications
  ViiV Healthcare
  Research Triangle Park, NC

  Disclosure: ViiV Healthcare: Employee, Shareholder
• SS

  Soya Sam, PhD

  Senior Research Project Director
  Lifespan
  Providence, RI

  Disclosure: Nothing to disclose
• WS

  William Spreen, PharmD

  R&D, Medicine Development Leader
  ViiV Healthcare
  Research Triangle Park, North Carolina

  Disclosure: ViiV Healthcare: Employee
• AC

  Angela Caliendo, MD, PhD

  Professor
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose
• PW

  Peter Williams, Ph.D.

  Dr
  Janssen Research & Development, LLC
  Beerse, Antwerpen, Belgium

  Disclosure: Johnson & Johnson: Employee, Shareholder
• SA

  Samuel Ayaya, MD

  Professor
  Academic Model Providence Access to Healthcare (AMPATH)
  Eldoret, Western, Kenya

  Disclosure: Nothing to disclose
• RV

  Rodica Van Solingen-Ristea, MD

  Clinical Leader
  Janssen Research & Development, LLC
  Beerse, Antwerpen, Belgium

  Disclosure: Janssen: Employee
• JH

  Joseph Hogan, PhD

  Professor
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose
• MS

  Mark Shaefer, PharmD

  Global Medical Lead, Cabotegravir
  ViiV Healthcare
  Chapel Hill, NC

  Disclosure: ViiV Healthcare: Employee
• RK

  Rami Kantor, MD

  Professor
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose

Moderator(s)

• 

  Anna Person, MD

  Associate Professor of Medicine
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: Nothing to disclose
• 

  Babafemi Taiwo, MBBS

  Gene Stollerman Professor of Medicine Chief, Division of Infectious Diseases
  Northwestern University
  Chicago, IL

  Disclosure: Gilead Sciences, Inc.: Consultant
  GlaxoSmithKline/ViiV Healthcare: Consultant
  Merck: Consultant

Presenting Author(s)

• GH

  Gregory Huhn, MD

  Associate Professor, Infectious Diseases
  The Ruth M. Rothstein CORE Center
  Chicago, IL

  Disclosure: Gilead: Consultant, Grant/Research Support
  Janssen: Consultant, Grant/Research Support
  Proteus: Grant/Research Support
  US National Institutes of Health: Research Grant or Support
  ViiV: Consultant, Grant/Research Support
• KM

  Kathleen McManus, MD, MSCR

  Assistant Professor
  University of Virginia
  Charlottesville, VA

  Disclosure: Gilead Sciences, Inc: Shareholder
• HS

  Hala Shamsuddin, MD

  Dr.
  Merck & Co., Inc.
  North Wales, PA

  Disclosure: Merck: Employee
• PT

  Paula Teichner, PharmD

  Field Medical Director
  ViiV Healthcare
  Research Triangle Park, NC

  Disclosure: ViiV Healthcare: Employee
• SH

  Sabina Holland, MD

  Assistant Professor
  Brown University
  Providence, RI

  Disclosure: Nothing to disclose